Skip to main content
    S

    Stereotaxis Inc (STXS)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX

    $0.81
    -0.04 (-4.48%)

    Market Cap: $85.02M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    19%(5/27)
    Avg Surprise
    -12.25%

    Upcoming Estimates

    Reports Mar 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.05
    Range-$0.05 - -$0.04
    5 analysts
    Revenue Consensus
    $8.91M
    Range$7.84M - $9.55M
    5 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.02
    Range-$0.02 - -$0.02
    1 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.03+33.3%
    60d ago-$0.03+33.3%
    30d ago-$0.03+33.3%
    7d ago-$0.03+33.3%
    Current-$0.02
    Revenue Consensus
    $9.50M
    Range$9.50M - $9.50M
    2 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-5.33xFCF Yield-18.77%
    Profitability
    Profit Margin-70.90%Operating Margin-65.00%
    ROE-117.40%ROIC-62.43%
    Financial Health
    Debt/Equity0.34xInterest Coverage75.82x
    Current Ratio1.08xQuick Ratio0.67x
    Trading Statistics
    Beta1.40Avg Volume958.81K
    52-Week High$2.8652-Week Low$0.80

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 27.8% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 34.2, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$0.95
    SMA 20$0.96
    SMA 50$1.12
    SMA 200$1.62
    EMA 10$0.92
    EMA 20$0.97
    EMA 50$1.10
    EMA 200$1.56

    MACD

    Line: -0.06Signal: -0.06Hist: -0.01

    ADX

    ADX: 35.0+DI: 16.1-DI: 32.3

    Aroon & PSAR

    Aroon Up80.0
    Aroon Down88.0
    PSAR$1.20

    Bollinger Bands

    Upper Band$1.14
    Lower Band$0.77
    %B Position3845%(Upper)
    Band Width0.09

    RSI (14-Day)

    Neutral
    34.2

    Momentum Oscillators

    Stoch %K7.7
    Stoch %D17.6
    Williams %R-98.7
    ROC (10d)-8.5%
    Momentum-0.07
    CCI (20d)-125.3
    MFI (14d)29.3

    Volatility Measures

    ATR (14d)$0.10(11.8%)
    StdDev (20d)0.09
    Hist Vol99.9%(High)

    Volume Flow

    VWAP$0.82
    OBV-13.0M
    AD Line-13.1M
    CMF (20d)-0.136

    Volume Metrics

    Avg Vol (20d)962.3K
    Vol Ratio0.7x
    VWMA (20d)$0.93

    Pivot Points

    R3$0.96
    R2$0.93
    R1$0.88
    Pivot Point$0.85
    S1$0.81
    S2$0.78
    S3$0.74

    Advanced Oscillators

    TSI-21.78
    Ultimate Osc39.0
    KST-156.46

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about STXS

    News

    STXS Valuation

    GNG's valuation label for STXS is Undervalued. It trades at 19.6x forward earnings.

    Forward P/E
    19.6x
    P/FCF
    -5.3x
    P/B
    3.9x
    STXS valuation multiples

    STXS Profitability: Margins, ROIC and FCF

    Stereotaxis (STXS) has a gross margin of 52.5%, an operating margin of -65.0% and a net margin of -70.9%. It posts -62.4% ROIC and a -49.2% FCF margin.

    Gross margin
    52.5%
    Operating margin
    -65.0%
    Net margin
    -70.9%
    ROIC
    -62.4%
    ROE
    -117.4%
    FCF margin
    -49.2%
    FCF yield
    -18.8%
    STXS financial statements

    Stereotaxis Competitors

    The companies most similar to Stereotaxis (STXS) include KORU Medical Systems, Daxor and Anbio Biotechnology Class A Ordinary Shares.

    Sector: Healthcare

    Companies most similar to Stereotaxis

    STXS Analyst Ratings

    Stereotaxis (STXS) has a Buy consensus from 3 analysts: 3 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    1
    Buy
    2
    Hold
    0
    Sell
    0
    Strong Sell
    0
    STXS stock forecast

    STXS Bull Case vs Bear Case

    Bull case

    • STXS grew quarterly revenue 19.6% year over year.

    Bear case

    • STXS has a -70.9% net profit margin.
    • STXS beat EPS estimates in 12.5% of its last 8 reported quarters.

    STXS Earnings: Beat Rate and Next Report

    Stereotaxis (STXS) beat the EPS estimate in 1 of the last 8 quarters (12.5%). Its next report is expected on Mar 8, 2027.

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -17.9%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.05
    STXS earnings history

    STXS Earnings Date

    STXS reports Mar 8, 2027. The date is estimated.

    STXS Earnings Call

    The latest STXS earnings call transcript on file is labeled 2026Q1.

    Read the 2026Q1 transcript

    See insider activity

    Updated Nov 16, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About STXS

    When does STXS report earnings?

    Stereotaxis Inc (STXS) is expected to report earnings on Mar 8, 2027.

    Does STXS pay dividends?

    Stereotaxis Inc (STXS) does not currently pay a regular dividend.

    What is STXS's market cap?

    Stereotaxis Inc (STXS) has a market capitalization of $85.02M with a current stock price of $0.81.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.